Delivered-To: sometime5858@gmail.com
Received: by 2002:a9d:6153:0:0:0:0:0 with SMTP id c19-v6csp1377356otk;
        Fri, 14 Sep 2018 17:32:09 -0700 (PDT)
X-Google-Smtp-Source: ANB0VdbDfjumbaL3lRYeTRnHNxz5eUjnhCrxgsHF3rB2SWPVKBtW0/ryPEizrtFgplS1srvUyQ6p
X-Received: by 2002:a1c:610b:: with SMTP id v11-v6mr4261577wmb.20.1536971529349;
        Fri, 14 Sep 2018 17:32:09 -0700 (PDT)
ARC-Seal: i=1; a=rsa-sha256; t=1536971529; cv=none;
        d=google.com; s=arc-20160816;
        b=pHQ1Ok++ipUBISmND5DVwRZrHM/XKNAHCTDe1F9T1YH/XGZhzx33zT9vP1wSWiA7sG
         RXXBhE9mQ0lLyj4Y4aFU4irMu6kqvxg7EbYQl3EzRwugFE7s8sQEQwOjxCH8Vlng9kN9
         Z7apZl/POj5VI+/bMZWC1ze71YBNQuHdHLxn5/AfsdLMtMK4hu6RiGtZyajyNmVB31HV
         GviQgh0wDYQk3tlfR5Ftxzs1sqC6jziVp6R7pyN8JRrhLaIfiRFYBvFVNuwqzcQGpezJ
         F5SMmdK9XnMH2XUIdb/dHHXwiWa3rAwEWLtkPAt1o3Z/9QYMZBgCUIaFRe8Kcs4uO7Tf
         cpgw==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=mime-version:spamdiagnosticmetadata:spamdiagnosticoutput
         :content-language:accept-language:message-id:deferred-delivery:date
         :thread-index:thread-topic:subject:from:dkim-signature;
        bh=6ydisITjFU6aiEvhSkdmRIRMJteEzWNDmoZSK172Dz0=;
        b=cVVRSohjhXfChcXTOweQmPOfJPyWik2KC6jDaHyNJQbcZ2NMZhlpl1NvXrnMejKW7g
         0gURix8jk7QDBqR6tCJfUxEHO1DkutnwVFR03OhLEE86CcVgLCv7EzgBlfLzhG7DPUs3
         glMNUWg26L6u4djwPFnULxdMN+pWdlox93qSD94UOYMYkHeFzez3yIg5VJg7P28EYpHg
         Pj6VW4zEE+FZ9Uo6k9tqZn7BN77DdVahe1Xw4y3KrAm8iqZVwEuHvucZBvLoGvdTAEOe
         0KD2mx9xnTonhwJLc/7DqED8QdybvqBSoyK8xEQEEzVic7SSHt1l3I5oLlI9ZmfCSZbe
         wDOw==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@NucleusNetwork.onmicrosoft.com header.s=selector1-nucleusnetwork-com-au header.b=VnCIrRDH;
       spf=pass (google.com: domain of reply@nucleusnetwork.com.au designates 104.47.116.131 as permitted sender) smtp.mailfrom=reply@nucleusnetwork.com.au
Return-Path: <reply@nucleusnetwork.com.au>
Received: from AUS01-ME1-obe.outbound.protection.outlook.com (mail-me1aus01on0131.outbound.protection.outlook.com. [104.47.116.131])
        by mx.google.com with ESMTPS id g20-v6si377290wme.182.2018.09.14.17.32.06
        (version=TLS1_2 cipher=ECDHE-RSA-AES128-SHA bits=128/128);
        Fri, 14 Sep 2018 17:32:09 -0700 (PDT)
Received-SPF: pass (google.com: domain of reply@nucleusnetwork.com.au designates 104.47.116.131 as permitted sender) client-ip=104.47.116.131;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@NucleusNetwork.onmicrosoft.com header.s=selector1-nucleusnetwork-com-au header.b=VnCIrRDH;
       spf=pass (google.com: domain of reply@nucleusnetwork.com.au designates 104.47.116.131 as permitted sender) smtp.mailfrom=reply@nucleusnetwork.com.au
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
 d=NucleusNetwork.onmicrosoft.com; s=selector1-nucleusnetwork-com-au;
 h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck;
 bh=6ydisITjFU6aiEvhSkdmRIRMJteEzWNDmoZSK172Dz0=;
 b=VnCIrRDHrwEWtnTzAb0N2tGzz4DwHTZg5wjXxg3M/8qomi4SfmsnA16XmhAAaVwIVgejyposr/n9TzdFkRIgzTzde+znrsk3jvqWgwV74sImeqjMQrnvpKVu786iRo9PnVlkytbg4AzmXUM4+IBN6mKtOH01rfaalKcC3RFmS6g=
Received: from SYXPR01MB0463.ausprd01.prod.outlook.com (10.162.73.19) by
 SYXPR01MB1279.ausprd01.prod.outlook.com (10.171.36.143) with Microsoft SMTP
 Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id
 15.20.1143.15; Sat, 15 Sep 2018 00:32:00 +0000
Received: from SYXPR01MB0463.ausprd01.prod.outlook.com
 ([fe80::70be:8c4e:bc64:2cfb]) by SYXPR01MB0463.ausprd01.prod.outlook.com
 ([fe80::70be:8c4e:bc64:2cfb%9]) with mapi id 15.20.1122.021; Sat, 15 Sep 2018
 00:32:00 +0000
From: Centre for Clinical Studies <reply@nucleusnetwork.com.au>
Subject: Weekly Update | Centre for Clinical Studies
Thread-Topic: Weekly Update | Centre for Clinical Studies
Thread-Index: AdRL/gjufUuEFcWZQ5i2IUXRmHbLPw==
Date: Sat, 15 Sep 2018 00:30:50 +0000
Deferred-Delivery: Sat, 15 Sep 2018 00:30:00 +0000
Message-ID:
 <SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180@SYXPR01MB0463.ausprd01.prod.outlook.com>
Accept-Language: en-AU, en-US
Content-Language: en-US
X-Hashtags: #Newsletters
X-MS-Has-Attach: yes
X-MS-TNEF-Correlator:
authentication-results: spf=none (sender IP is )
 smtp.mailfrom=reply@nucleusnetwork.com.au; 
x-ms-exchange-messagesentrepresentingtype: 1
x-originating-ip: [49.255.134.62]
x-ms-publictraffictype: Email
x-microsoft-exchange-diagnostics:
 1;SYXPR01MB1279;6:styJhhVw4a7ZL+JB+1sAp22DEstMTvWNu/wrPcWqlQIXjrd31H5DvFpnaAU1p4LwLxmKGJh4RvdugfRsGlU05F0m6hHym0zr4ahSXgjSHk1JUotCIahVLSVgRTVjhnoJTz+RiMFAu52LLTWcQtQXhKSl/RB5llK1SeNFmBsjWYS/mxDwBk4cf7ZDBAPw08mVRVSBLRQPEy3JPgQ6G6oyg5eaY3/jkY0Bust/nI/1iM6rjX5KkTVtgQ1cokt8oYWlg/K2b3qv88sUKMyflKk27J2aeIK+gs9Jlkv6x/lxZIXdtVVMDZzw8x11WuD0DPWLbDj142riJAiISGRHeujZvzInZjATGC4WiIMVEK2wr2i5my3Rmd9RFvt45sF+XBZ7FwvsvOGcGWNwyxQI4orFQ6DDS65n0CLFi6YeilruD/1YN7UFYyNt0LH4zmklUarK6tb520ueindHYhJR0RiTuA==;5:bCoC4BN5iIOjSQvf1YpKfOhNqzyahAty8hdiG0bsS92egd+1wm61daaG8NjeSy4/y8iWB0A8zY8+k4Sk469OF+RxItdpyThPS/euSkZSthYIRt/EP3+DEvh4swdqYjreDdoJivpB7TsPuz9G+HbDqfewR/s11od7l5vYM9E5mJ4=;7:7eRPOYhnHzAmmhmYGyK9Z6CXEAWB8LsLFTrU2mxKbdpw0h/KXzoWSt7nIxiBsf/f7umzJODBf4DgQIWt/4yeKDUlbE//Jq1cBUTr174wrO9C/f2KyT9t2UgbPe2cyRjSK7+/t8cfNTVLWrH/VsDwOu6edQnaMhx/hFN+2mMiwCkCHxgbmgG9NJcyDqla05L5y/rJpKxn2Mk2GWw7Anwt68ojLoDeyYRhAeHHjDEiALvhIcjRRw+v8brGio66MhuB
x-ms-office365-filtering-correlation-id: 78ee5e0d-c872-4443-f3c3-08d61aa2a6dc
x-microsoft-antispam:
 BCL:0;PCL:0;RULEID:(7020095)(4652040)(8989137)(4534165)(4627221)(201703031133081)(201702281549075)(8990107)(5600074)(711020)(2017052603328)(7153060)(49563074)(7193020);SRVR:SYXPR01MB1279;
x-ms-traffictypediagnostic: SYXPR01MB1279:
x-ms-exchange-sharedmailbox-routingagent-processed: True
x-microsoft-antispam-prvs:
 <SYXPR01MB1279B5B5273F5AD3A51FA827F4180@SYXPR01MB1279.ausprd01.prod.outlook.com>
x-exchange-antispam-report-test:
 UriScan:(28532068793085)(148322886591682)(277860510277777)(28212336023702)(31418570063057)(277809949798613)(254730959083279)(86561027422486)(81227570615382)(46150409022019);
x-ms-exchange-senderadcheck: 1
x-exchange-antispam-report-cfa-test:
 BCL:0;PCL:0;RULEID:(8211001083)(102415395)(6040522)(2401047)(5005006)(8121501046)(3002001)(10201501046)(3231311)(944501410)(52105095)(93006095)(93001095)(149027)(150027)(6041310)(201703131423095)(201702281528075)(20161123555045)(201703061421075)(201703061406153)(20161123560045)(20161123564045)(20161123562045)(20161123558120)(201708071742011)(7699050);SRVR:SYXPR01MB1279;BCL:0;PCL:0;RULEID:;SRVR:SYXPR01MB1279;
x-forefront-prvs: 0796EBEDE1
x-forefront-antispam-report:
 SFV:NSPM;SFS:(10019020)(1496009)(366004)(396003)(346002)(376002)(39860400002)(136003)(189003)(9763003)(199004)(55016002)(186003)(5250100002)(25786009)(19627405001)(68770200003)(15650500001)(99286004)(2420400007)(6116002)(790700001)(3846002)(99936001)(10126004)(2900100001)(486006)(109986005)(39060400002)(102836004)(26005)(74316002)(7416002)(733005)(6666003)(6306002)(236005)(53936002)(7736002)(316002)(6506007)(6436002)(7336002)(54896002)(54556002)(7406005)(7276002)(9686003)(7366002)(5660300001)(1671002)(476003)(105586002)(106356001)(861006)(74482002)(33656002)(7066003)(97736004)(65686004)(8676002)(68736007)(881003)(66066001)(606006)(7696005)(478600001)(81156014)(14454004)(88732003)(89122003)(90282003)(76576003)(2906002)(86362001)(81166006)(8936002)(7110500001)(256004)(15398625002);DIR:OUT;SFP:1102;SCL:1;SRVR:SYXPR01MB1279;H:SYXPR01MB0463.ausprd01.prod.outlook.com;FPR:;SPF:None;LANG:en;PTR:InfoNoRecords;MX:1;A:1;
received-spf: None (protection.outlook.com: nucleusnetwork.com.au does not
 designate permitted sender hosts)
x-microsoft-antispam-message-info:
 OpvatTg0nHwZwAeDyumHV2t8OCT4V6tUFc+RD3Trt2VMZBHK/OxifMsni7kSQJjD/VfBrDdptX2VqnX4apuTPAWQYHI/7eHY1j4B0LaeviKvnt0k1xufBnu67tOAY3MljcJ9wum9ORIWvFz+PlFnFaqPAnMTvxsD3DWB8h6HyP6so+LjQ/ddknEAixmwGTITS4180o0XH4dQ+1hMoOY7Zx9d8udSd+qoFXGKEp+vH6bIq5RzuqGjuGvz8CcrJmXuJUIMGIzYmsCPUsLtzNngsp4Um79T5YRTITUjt6qtcQLMdXfzvoYz36B7dg6WuoyukaPS5WVVPoFVytyQkbJ6Y2eVjK+1jouozZEBu6Om3w8=
spamdiagnosticoutput: 1:99
spamdiagnosticmetadata: NSPM
Content-Type: multipart/related;
	boundary="_007_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_";
	type="multipart/alternative"
MIME-Version: 1.0
X-OriginatorOrg: nucleusnetwork.com.au
X-MS-Exchange-CrossTenant-Network-Message-Id: 78ee5e0d-c872-4443-f3c3-08d61aa2a6dc
X-MS-Exchange-CrossTenant-originalarrivaltime: 15 Sep 2018 00:30:58.5854
 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: 789e47a3-a852-4653-860e-4105eaf939ce
X-MS-Exchange-Transport-CrossTenantHeadersStamped: SYXPR01MB1279
X-TUID: vOuA4uhRusvb

--_007_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_
Content-Type: multipart/alternative;
	boundary="_000_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_"

--_000_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable




Centre for Clinical Studies. It's that time of the week again! Finding the =
perfect study has never been easier, check out the categories below and fol=
low the link for more information.
centrefor
clinicalstudies

It's that time of the week again! Finding the perfect study has never been =
easier, check out the categories below and follow the link for more informa=
tion.

To register your interest, simply respond to this email or feel free to giv=
e our friendly Recruitment team a call on 1800 243 733.



***FEATURE STUDY***

THE GIANT STUDY $8,700
35 Nights Inpatient & 4 Outpatient visit
This biggest study we have to offer, needs you!

CLICK HERE<http://clinicalstudies.com.au/wp-content/uploads/2018/09/Get-rea=
dy-for-this-GIANT-study.pdf?utm_source=3Doutlook&utm_campaign=3DOM-feature-=
1-APL2-101> for more information


5 STAR STUDIES
These studies are 5 star ratings! Check them out
CLICK HERE<http://clinicalstudies.com.au/wp-content/uploads/2018/09/5SS_NM_=
16SEP2018.pdf?utm_source=3Doutlook&utm_campaign=3DOM-five-star-studies> for=
 more information


SHORT INPATIENT
If you can't commit to a long inpatient stay, these easy studies may be jus=
t the right fit.
CLICK HERE<http://clinicalstudies.com.au/wp-content/uploads/2018/09/SI-OM-S=
AT-15-Sept.pdf?utm_source=3Doutlook&utm_campaign=3DOM-short-inpatient> for =
more information


STUDIES WITH A DIFFERENCE
Looking for something a little bit different? Check out these options
CLICK HERE<http://clinicalstudies.com.au/wp-content/uploads/2018/09/ALL-SWD=
-SAT-MON-Sept.pdf?utm_source=3Doutlook&utm_campaign=3DOM-studies-with-a-dif=
ference> for more information


QUICK & EASY
After a study that is quick and easy ? These studies should suit you!
CLICK HERE<http://clinicalstudies.com.au/wp-content/uploads/2018/09/QE-OM.p=
df?utm_source=3Doutlook&utm_campaign=3DOM-quick-and-easy> for more informat=
ion


HIGH REIMBURSEMENT
These studies are typically longer in duration with a larger time commitmen=
t.
CLICK HERE<http://clinicalstudies.com.au/wp-content/uploads/2018/09/HR_MALE=
S_15-16SEP.pdf?utm_source=3Doutlook&utm_campaign=3DOM-high-reimbursement> f=
or more information


FINISHED IN A FORTNIGHT
We have a variety of studies that you can complete in a fortnight - follow =
up visits and all!
CLICK HERE<http://clinicalstudies.com.au/wp-content/uploads/2018/09/FIF-OM.=
pdf?utm_source=3Doutlook&utm_campaign=3DOM-finish-in-a-fortnight> for more =
information


SOME THINGS YOU MIGHT WANT TO KNOW ABOUT US

If you're wondering where we are, just view our handy map<http://clinicalst=
udies.com.au/wp-content/uploads/2018/05/How-to-get-to-CFCS.pdf>

Let us walk you through the Participant Journey<https://clinicalstudies.com=
.au/participants-journey/>

Spare time? Check out our awesome blog<https://clinicalstudies.com.au/blog/=
>

Hear what our amazing volunteers have to say in their testimonials<https://=
clinicalstudies.com.au/testimonial/>!


Don't forget, we're also offering

$100 TO REFER A FRIEND!
Check out our Terms and Conditions<http://clinicalstudies.com.au/wp-content=
/uploads/2017/12/Referral-Terms-and-Conditions.pdf>
Kind regards,

Recruitment Team

Centre for Clinical Studies
Office: | Level 5 Burnet Institute | AMREP Precinct | 89 Commercial Road | =
Victoria 3004 | Australia
T: 1800 243 733 | Reception: 03 9076 8957
reply@nucleusnetwork.com.au<mailto:reply@nucleusnetwork.com.au> | www.clini=
calstudies.com.au<http://www.clinicalstudies.com.au/>
Nucleus Network, Australia's Clinical Research Centre, operates in associat=
ion with Centre for Clinical Studies, Clinical Trials Consulting and its ne=
twork partners
1800 243 733

[cid:image002.png@01D244DB.B31610A0]<https://www.facebook.com/CfCStudies/> =
 [cid:image004.png@01D244DB.B31610A0] <https://www.instagram.com/centreforc=
linicalstudies/>   [cid:image005.png@01D244DB.B31610A0] <https://twitter.co=
m/cfcstudies>   [cid:image010.png@01D244DB.B31610A0] <https://www.youtube.c=
om/channel/UCxWbVDcH-sfT8zaZA4uvQQw>
Find us on Facebook, Instagram, Twitter and YouTube

If you do not wish to receive any further emails from us then please reply =
to this email with the word 'UNSUBSCRIBE' in the subject box.





To stop receiving messages from Recruitment Team Members<https://outlook.of=
fice365.com/owa/recruitmentteammembers@nucleusnetwork.com.au/groupsubscript=
ion.ashx?realm=3Dnucleusnetwork.com.au&source=3DEscalatedMessage&action=3Dc=
onversations> group, stop following it<https://outlook.office365.com/owa/re=
cruitmentteammembers@nucleusnetwork.com.au/groupsubscription.ashx?realm=3Dn=
ucleusnetwork.com.au&source=3DEscalatedMessage&action=3Dunsubscribe>.





--_000_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-micr=
osoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"http:=
//www.w3.org/TR/REC-html40">
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii"=
>
<meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Semibold";
	panose-1:2 11 7 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Monotype Corsiva";
	panose-1:3 1 1 1 1 2 1 1 1 1;}
@font-face
	{font-family:"Neue Haas Grotesk Text Pro";}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:#0563C1;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-priority:99;
	color:#954F72;
	text-decoration:underline;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{mso-style-priority:1;
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-language:EN-US;}
p.msonormal0, li.msonormal0, div.msonormal0
	{mso-style-name:msonormal;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.EmailStyle20
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle21
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle22
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle23
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle24
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle25
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle26
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle27
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle28
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle29
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle30
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle31
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle32
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle33
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle34
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle35
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle36
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle37
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle38
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle39
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle40
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle41
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle42
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle43
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle44
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle45
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle46
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle47
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle48
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle49
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.EmailStyle51
	{mso-style-type:personal-reply;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
.MsoChpDefault
	{mso-style-type:export-only;
	font-size:10.0pt;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=3D"EN-AU" link=3D"#0563C1" vlink=3D"#954F72">
<div class=3D"WordSection1">
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal"><span style=3D"font-size:6.0pt"><o:p>&nbsp;</o:p></s=
pan></p>
<p class=3D"MsoNormal"><span style=3D"font-size:6.0pt;color:white">Centre f=
or Clinical Studies. It&#8217;s that time of the week again! Finding the pe=
rfect study has never been easier, check out the categories below and follo=
w the link</span><span style=3D"color:white">
 for more information.<o:p></o:p></span></p>
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" style=3D"border-collapse:collapse">
<tbody>
<tr style=3D"height:33.55pt">
<td width=3D"557" valign=3D"top" style=3D"width:417.8pt;padding:0cm 5.4pt 0=
cm 5.4pt;height:33.55pt">
<p class=3D"MsoNormal"><b><span lang=3D"EN-US" style=3D"font-size:18.0pt;fo=
nt-family:&quot;Neue Haas Grotesk Text Pro&quot;,sans-serif;color:#4B54FF">=
centre</span></b><span lang=3D"EN-US" style=3D"font-size:18.0pt;font-family=
:&quot;Neue Haas Grotesk Text Pro&quot;,sans-serif;color:#4B54FF">for<b><o:=
p></o:p></b></span></p>
<p class=3D"MsoNormal"><b><span lang=3D"EN-US" style=3D"font-size:18.0pt;fo=
nt-family:&quot;Neue Haas Grotesk Text Pro&quot;,sans-serif;color:#4B54FF">=
clinical</span></b><span lang=3D"EN-US" style=3D"font-size:18.0pt;font-fami=
ly:&quot;Neue Haas Grotesk Text Pro&quot;,sans-serif;color:#4B54FF">studies=
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:12.0pt"><br>
It&#8217;s that time of the week again! Finding the perfect study has never=
 been easier, check out the categories below and follow the link for more i=
nformation.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:12.0pt"><o:p>&nbsp;</o:p></=
span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:12.0pt">To register your in=
terest, simply respond to this email or feel free to give our friendly Recr=
uitment team a call on
<b><u>1800 243 733</u></b>. &nbsp;<o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" style=3D"border-collapse:collapse">
<tbody>
<tr style=3D"height:3.4pt">
<td width=3D"556" valign=3D"top" style=3D"width:417.05pt;border:solid white=
 2.25pt;border-bottom:solid white 6.0pt;background:#E75A57;padding:0cm 5.4p=
t 0cm 5.4pt;height:3.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><spa=
n style=3D"font-size:8.0pt;color:black"><br>
</span></b><b><span style=3D"font-size:20.0pt;color:white">***FEATURE STUDY=
***<o:p></o:p></span></b></p>
</td>
</tr>
<tr style=3D"height:3.35pt">
<td width=3D"556" valign=3D"top" style=3D"width:417.05pt;border-top:none;bo=
rder-left:solid white 2.25pt;border-bottom:solid white 6.0pt;border-right:s=
olid white 2.25pt;background:#E75A57;padding:0cm 5.4pt 0cm 5.4pt;height:3.3=
5pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><spa=
n style=3D"font-size:16.0pt;color:white">THE GIANT STUDY $8,700<o:p></o:p><=
/span></b></p>
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b>35 N=
ights Inpatient &amp; 4 Outpatient visit<o:p></o:p></b></p>
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b>This=
 biggest study we have to offer, needs you!<o:p></o:p></b></p>
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><o:p=
>&nbsp;</o:p></b></p>
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><a h=
ref=3D"http://clinicalstudies.com.au/wp-content/uploads/2018/09/Get-ready-f=
or-this-GIANT-study.pdf?utm_source=3Doutlook&amp;utm_campaign=3DOM-feature-=
1-APL2-101">CLICK HERE</a> for more information<o:p></o:p></b></p>
</td>
</tr>
<tr>
<td width=3D"556" valign=3D"top" style=3D"width:417.05pt;border:solid white=
 2.25pt;border-top:none;background:#B9BCFF;padding:0cm 5.4pt 0cm 5.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"margin-bottom:12.0pt;text-=
align:center">
<b><span style=3D"font-size:8.0pt"><br>
</span></b><b><span style=3D"font-size:16.0pt">5 STAR STUDIES </span></b><b=
r>
<strong><span style=3D"font-family:&quot;Calibri&quot;,sans-serif;color:bla=
ck;font-weight:normal">These studies are 5 star ratings! Check them out</sp=
an></strong><span style=3D"color:#F2F2F2"><br>
</span><b><a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2018/=
09/5SS_NM_16SEP2018.pdf?utm_source=3Doutlook&amp;utm_campaign=3DOM-five-sta=
r-studies">CLICK HERE</a> for more information<span style=3D"color:black"><=
o:p></o:p></span></b></p>
</td>
</tr>
<tr>
<td width=3D"556" valign=3D"top" style=3D"width:417.05pt;border:solid white=
 2.25pt;border-top:none;background:#979CFF;padding:0cm 5.4pt 0cm 5.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"margin-bottom:12.0pt;text-=
align:center">
<b><span style=3D"font-size:16.0pt"><br>
SHORT INPATIENT </span></b><br>
<strong><span style=3D"font-family:&quot;Calibri&quot;,sans-serif;color:bla=
ck;font-weight:normal">If you can&#8217;t commit to a long inpatient stay, =
these easy studies may be just the right fit.
</span></strong><b><br>
<a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2018/09/SI-OM-S=
AT-15-Sept.pdf?utm_source=3Doutlook&amp;utm_campaign=3DOM-short-inpatient">=
CLICK HERE</a> for more information<o:p></o:p></b></p>
</td>
</tr>
<tr>
<td width=3D"556" valign=3D"top" style=3D"width:417.05pt;border:solid white=
 2.25pt;border-top:none;background:#B7BAFF;padding:0cm 5.4pt 0cm 5.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"margin-bottom:16.0pt;text-=
align:center">
<b><span style=3D"font-size:8.0pt"><br>
</span></b><b><span style=3D"font-size:16.0pt">STUDIES WITH A DIFFERENCE </=
span></b><br>
<strong><span style=3D"font-family:&quot;Calibri&quot;,sans-serif;font-weig=
ht:normal">Looking for something a little bit different? Check out these op=
tions</span></strong><b><br>
<a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2018/09/ALL-SWD=
-SAT-MON-Sept.pdf?utm_source=3Doutlook&amp;utm_campaign=3DOM-studies-with-a=
-difference">CLICK HERE</a> for more information</b><b><span style=3D"font-=
size:16.0pt"><o:p></o:p></span></b></p>
</td>
</tr>
<tr>
<td width=3D"556" valign=3D"top" style=3D"width:417.05pt;border:solid white=
 2.25pt;border-top:none;background:#979CFF;padding:0cm 5.4pt 0cm 5.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"margin-bottom:12.0pt;text-=
align:center">
<b><span style=3D"font-size:8.0pt"><br>
</span></b><b><span style=3D"font-size:16.0pt">QUICK &amp; EASY </span></b>=
<br>
<strong><span style=3D"font-family:&quot;Calibri&quot;,sans-serif;font-weig=
ht:normal">After a study that is quick and easy ? These studies should suit=
 you!</span></strong><b><br>
<a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2018/09/QE-OM.p=
df?utm_source=3Doutlook&amp;utm_campaign=3DOM-quick-and-easy">CLICK HERE</a=
> for more information<o:p></o:p></b></p>
</td>
</tr>
<tr>
<td width=3D"556" valign=3D"top" style=3D"width:417.05pt;border:solid white=
 2.25pt;border-top:none;background:#B7BAFF;padding:0cm 5.4pt 0cm 5.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"margin-bottom:12.0pt;text-=
align:center">
<b><br>
</b><b><span style=3D"font-size:16.0pt">HIGH REIMBURSEMENT </span></b><br>
<strong><span style=3D"font-family:&quot;Calibri&quot;,sans-serif;color:bla=
ck;font-weight:normal">These studies are typically longer in duration with =
a larger time commitment.</span></strong><span style=3D"color:black"><br>
</span><b><a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2018/=
09/HR_MALES_15-16SEP.pdf?utm_source=3Doutlook&amp;utm_campaign=3DOM-high-re=
imbursement">CLICK HERE</a> for more information<strong><span style=3D"font=
-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></str=
ong></b></p>
</td>
</tr>
<tr>
<td width=3D"556" valign=3D"top" style=3D"width:417.05pt;border:solid white=
 2.25pt;border-top:none;background:#979CFF;padding:0cm 5.4pt 0cm 5.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"margin-bottom:12.0pt;text-=
align:center">
<b><span style=3D"font-size:8.0pt"><br>
</span></b><b><span style=3D"font-size:16.0pt">FINISHED IN A FORTNIGHT</spa=
n></b><br>
<strong><span style=3D"font-family:&quot;Calibri&quot;,sans-serif;color:bla=
ck;font-weight:normal">We have a variety of studies that you can complete i=
n a
</span></strong><strong><span style=3D"font-family:&quot;Calibri&quot;,sans=
-serif;font-weight:normal">fortnight<span style=3D"color:black">
</span>- <span style=3D"color:black">follow up visits and all!</span></span=
></strong><b><br>
<a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2018/09/FIF-OM.=
pdf?utm_source=3Doutlook&amp;utm_campaign=3DOM-finish-in-a-fortnight">CLICK=
 HERE</a> for more information</b><o:p></o:p></p>
</td>
</tr>
</tbody>
</table>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" style=3D"border-collapse:collapse">
<tbody>
<tr style=3D"height:27.65pt">
<td width=3D"557" style=3D"width:417.8pt;border:solid white 1.0pt;backgroun=
d:#3B3838;padding:0cm 5.4pt 0cm 5.4pt;height:27.65pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><spa=
n style=3D"font-size:14.0pt;color:white">SOME THINGS YOU MIGHT WANT TO KNOW=
 ABOUT US<o:p></o:p></span></b></p>
</td>
</tr>
<tr>
<td width=3D"557" style=3D"width:417.8pt;border:solid white 1.0pt;border-to=
p:none;background:#949494;padding:0cm 5.4pt 0cm 5.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">If you&=
#8217;re wondering where we are, just view our handy
<a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2018/05/How-to-=
get-to-CFCS.pdf">
map</a><o:p></o:p></p>
</td>
</tr>
<tr>
<td width=3D"557" style=3D"width:417.8pt;border:solid white 1.0pt;border-to=
p:none;background:#A6A6A6;padding:0cm 5.4pt 0cm 5.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Let us =
walk you through the
<u><a href=3D"https://clinicalstudies.com.au/participants-journey/">Partici=
pant Journey</a></u><o:p></o:p></p>
</td>
</tr>
<tr>
<td width=3D"557" style=3D"width:417.8pt;border:solid white 1.0pt;border-to=
p:none;background:#BFBFBF;padding:0cm 5.4pt 0cm 5.4pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Spare t=
ime? Check out our awesome
<u><a href=3D"https://clinicalstudies.com.au/blog/">blog</a></u><o:p></o:p>=
</p>
</td>
</tr>
<tr style=3D"height:4.35pt">
<td width=3D"557" style=3D"width:417.8pt;border:solid white 1.0pt;border-to=
p:none;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt;height:4.35pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Hear wh=
at our amazing volunteers have to say in their
<a href=3D"https://clinicalstudies.com.au/testimonial/">testimonials</a>!<o=
:p></o:p></p>
</td>
</tr>
</tbody>
</table>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal"><b>Don&#8217;t forget, we&#8217;re also offering<o:p=
></o:p></b></p>
<p class=3D"MsoNoSpacing" style=3D"margin-bottom:12.0pt"><strong><span styl=
e=3D"font-size:22.0pt;font-family:&quot;Calibri&quot;,sans-serif;color:#4B5=
4FF">$100</span></strong><b><span style=3D"font-size:22.0pt;color:#4B54FF">
<strong><span style=3D"font-family:&quot;Calibri&quot;,sans-serif">TO REFER=
 A&nbsp;FRIEND!</span></strong></span></b><u><span style=3D"color:black"><b=
r>
</span></u><b>Check out our <a href=3D"http://clinicalstudies.com.au/wp-con=
tent/uploads/2017/12/Referral-Terms-and-Conditions.pdf">
Terms and Conditions</a></b><o:p></o:p></p>
<p class=3D"MsoNormal">Kind regards,<o:p></o:p></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:22.0pt;font-family:&quot=
;Monotype Corsiva&quot;;mso-fareast-language:EN-AU">Recruitment Team<o:p></=
o:p></span></b></p>
<p class=3D"MsoNormal"><span style=3D"font-family:&quot;Arial&quot;,sans-se=
rif;color:#1F497D;mso-fareast-language:EN-AU"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#00B0F0;mso-fareast-language=
:EN-AU">Centre for Clinical Studies</span></b><span style=3D"color:#99CC00;=
mso-fareast-language:EN-AU">
</span><span style=3D"color:#1F497D;mso-fareast-language:EN-AU"><br>
Office: | Level 5 Burnet Institute | AMREP Precinct | 89 Commercial Road |&=
nbsp;Victoria 3004 | Australia<br>
T: </span><span style=3D"color:#1F4E79;mso-fareast-language:EN-AU">1800 243=
 733 |&nbsp;</span><span style=3D"color:#1F497D;mso-fareast-language:EN-AU"=
>Reception: 03 9076 8957
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"mso-fareast-language:EN-AU"><a href=
=3D"mailto:reply@nucleusnetwork.com.au">reply@nucleusnetwork.com.au</a> |
<a href=3D"http://www.clinicalstudies.com.au/"><b><span lang=3D"FR" style=
=3D"color:#00B0F0">www.clinicalstudies.com.au</span></b></a></span><b><span=
 lang=3D"FR" style=3D"color:#00B0F0;mso-fareast-language:EN-AU"><o:p></o:p>=
</span></b></p>
<p class=3D"MsoNormal"><b><i><span style=3D"color:#1F497D;mso-fareast-langu=
age:EN-AU">Nucleus Network, Australia's Clinical Research Centre, operates =
in association with Centre for Clinical Studies, Clinical Trials Consulting=
 and its network partners<o:p></o:p></span></i></b></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:24.0pt;color:black;mso-f=
areast-language:EN-AU">1800 243 733</span></b><span style=3D"color:black;ms=
o-fareast-language:EN-AU"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"mso-fareast-language:EN-AU"><o:p>&nbs=
p;</o:p></span></p>
<p class=3D"MsoNormal"><a href=3D"https://www.facebook.com/CfCStudies/"><sp=
an style=3D"color:#1F497D;mso-fareast-language:EN-AU;text-decoration:none">=
<img border=3D"0" width=3D"37" height=3D"37" style=3D"width:.3854in;height:=
.3854in" id=3D"Picture_x0020_10" src=3D"cid:image001.png@01D3E6F0.68361270"=
 alt=3D"cid:image002.png@01D244DB.B31610A0"></span></a><span style=3D"color=
:#1F497D;mso-fareast-language:EN-AU">&nbsp;
</span><a href=3D"https://www.instagram.com/centreforclinicalstudies/"><spa=
n style=3D"color:#1F497D;mso-fareast-language:EN-AU;text-decoration:none"><=
img border=3D"0" width=3D"37" height=3D"37" style=3D"width:.3854in;height:.=
3854in" id=3D"Picture_x0020_15" src=3D"cid:image002.png@01D3E6F0.68361270" =
alt=3D"cid:image004.png@01D244DB.B31610A0"></span></a><span style=3D"color:=
#1F497D;mso-fareast-language:EN-AU">&nbsp;&nbsp;</span><a href=3D"https://t=
witter.com/cfcstudies"><span style=3D"color:#1F497D;mso-fareast-language:EN=
-AU;text-decoration:none"><img border=3D"0" width=3D"37" height=3D"37" styl=
e=3D"width:.3854in;height:.3854in" id=3D"Picture_x0020_9" src=3D"cid:image0=
03.png@01D3E6F0.68361270" alt=3D"cid:image005.png@01D244DB.B31610A0"></span=
></a><span style=3D"color:#1F497D;mso-fareast-language:EN-AU">&nbsp;&nbsp;<=
/span><a href=3D"https://www.youtube.com/channel/UCxWbVDcH-sfT8zaZA4uvQQw">=
<span style=3D"color:#1F497D;mso-fareast-language:EN-AU;text-decoration:non=
e"><img border=3D"0" width=3D"37" height=3D"37" style=3D"width:.3854in;heig=
ht:.3854in" id=3D"Picture_x0020_13" src=3D"cid:image004.png@01D3E6F0.683612=
70" alt=3D"cid:image010.png@01D244DB.B31610A0"></span></a><span style=3D"co=
lor:#1F497D;mso-fareast-language:EN-AU">&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>=
</span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:9.0pt;mso-fareast-language:=
EN-AU">Find us on Facebook, Instagram, Twitter and YouTube<o:p></o:p></span=
></p>
<p class=3D"MsoNormal"><span style=3D"mso-fareast-language:EN-AU"><o:p>&nbs=
p;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:9.0pt">If you do not wish t=
o receive any further emails from us then please reply to this email with t=
he word &#8216;UNSUBSCRIBE&#8217; in the subject box.</span><span style=3D"=
font-size:12.0pt;color:#003F80"><o:p></o:p></span></p>
<div id=3D"a59ada49-a492-4f1d-ac57-74be3a4194fc">
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" width=3D"50" style=3D"width:37.5pt">
<tbody>
<tr style=3D"height:13.5pt">
<td style=3D"border:none;border-bottom:solid #EAEAEA 1.0pt;padding:0cm 0cm =
0cm 0cm;height:13.5pt">
<p class=3D"MsoNormal"><span style=3D"mso-fareast-language:EN-AU">&nbsp;<o:=
p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class=3D"MsoNormal"><span style=3D"display:none;mso-fareast-language:EN-=
AU"><o:p>&nbsp;</o:p></span></p>
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" width=3D"90%" style=3D"width:90.0%">
<tbody>
<tr style=3D"height:12.75pt">
<td style=3D"padding:0cm 0cm 0cm 0cm;height:12.75pt">
<p class=3D"MsoNormal" style=3D"line-height:12.75pt"><span style=3D"mso-far=
east-language:EN-AU">&nbsp;<o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style=3D"padding:0cm 0cm 0cm 0cm">
<p class=3D"MsoNormal" style=3D"line-height:12.75pt"><span style=3D"font-si=
ze:9.0pt;font-family:&quot;Segoe UI&quot;,sans-serif;color:#666666;mso-fare=
ast-language:EN-AU">To stop receiving messages from
<a href=3D"https://outlook.office365.com/owa/recruitmentteammembers@nucleus=
network.com.au/groupsubscription.ashx?realm=3Dnucleusnetwork.com.au&amp;sou=
rce=3DEscalatedMessage&amp;action=3Dconversations">
<span style=3D"font-family:&quot;Segoe UI Semibold&quot;,sans-serif;color:#=
0072C6;text-decoration:none">Recruitment Team Members</span></a> group,
<a href=3D"https://outlook.office365.com/owa/recruitmentteammembers@nucleus=
network.com.au/groupsubscription.ashx?realm=3Dnucleusnetwork.com.au&amp;sou=
rce=3DEscalatedMessage&amp;action=3Dunsubscribe">
<span style=3D"font-family:&quot;Segoe UI Semibold&quot;,sans-serif;color:#=
0072C6;text-decoration:none">stop following it</span></a>.<o:p></o:p></span=
></p>
</td>
</tr>
<tr style=3D"height:12.75pt">
<td style=3D"padding:0cm 0cm 0cm 0cm;height:12.75pt">
<p class=3D"MsoNormal" style=3D"line-height:12.75pt"><span style=3D"mso-far=
east-language:EN-AU">&nbsp;<o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class=3D"MsoNormal"><span style=3D"mso-fareast-language:EN-AU"><o:p>&nbs=
p;</o:p></span></p>
</div>
</div>
</body>
</html>

--_000_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_--

--_007_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_
Content-Type: image/png; name="image001.png"
Content-Description: image001.png
Content-Disposition: inline; filename="image001.png"; size=802;
	creation-date="Tue, 08 May 2018 07:17:15 GMT";
	modification-date="Tue, 08 May 2018 07:17:15 GMT"
Content-ID: <image001.png@01D3E6F0.68361270>
Content-Transfer-Encoding: base64
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--_007_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_
Content-Type: image/png; name="image002.png"
Content-Description: image002.png
Content-Disposition: inline; filename="image002.png"; size=1316;
	creation-date="Tue, 08 May 2018 07:17:15 GMT";
	modification-date="Tue, 08 May 2018 07:17:15 GMT"
Content-ID: <image002.png@01D3E6F0.68361270>
Content-Transfer-Encoding: base64
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--_007_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_
Content-Type: image/png; name="image003.png"
Content-Description: image003.png
Content-Disposition: inline; filename="image003.png"; size=992;
	creation-date="Tue, 08 May 2018 07:17:16 GMT";
	modification-date="Tue, 08 May 2018 07:17:16 GMT"
Content-ID: <image003.png@01D3E6F0.68361270>
Content-Transfer-Encoding: base64
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--_007_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_
Content-Type: image/png; name="image004.png"
Content-Description: image004.png
Content-Disposition: inline; filename="image004.png"; size=1282;
	creation-date="Tue, 08 May 2018 07:17:16 GMT";
	modification-date="Tue, 08 May 2018 07:17:16 GMT"
Content-ID: <image004.png@01D3E6F0.68361270>
Content-Transfer-Encoding: base64
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--_007_SYXPR01MB0463ADC3F5AAF26E7BEFED98C5180SYXPR01MB0463ausp_--
